Skip to main content
Clinical Trials/NL-OMON42483
NL-OMON42483CompletedPhase 3

RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial) - RAP and BEAT

PO International TRI Network, Research Center, Cardiovascular Dept., Shonan Kamakura General hospital0 sites300 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 5.4 General Inclusion Criteria
  • 1. Patient must be at least 18 years of age.
  • 2. Patient is able to verbally acknowledge an understanding of the associated risks, benefits
  • and treatment alternatives
  • 3. Patient who is expected to diagnose by coronary artery angiography or followed by PCI.
  • 4. Patient must agree to undergo all protocol-required follow-up examinations.
  • 5. Patient who can accept radial access.

Exclusion Criteria

  • 1. Patient has other medical illness (e.g., cancer or congestive heart failure) that may
  • cause non-compliance with the protocol, confound the data interpretation or is
  • associated with a limited life expectancy (i.e., less than one year).
  • 2. Hemodialysis patient

Investigators

Sponsor
PO International TRI Network, Research Center, Cardiovascular Dept., Shonan Kamakura General hospital

Similar Trials